Publs. oficiales TME Pharma N.V.

Acciones

Mercado cerrado - Euronext Paris Otros sitios de cotización 17:29:27 14/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,205 ^EUR	-5,09 %		-10,87 %	-10,87 %

25/04	TME Pharma N.V. presenta los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI
23/04	TME Pharma N.V. anuncia que el 33% de los pacientes que reciben NOX-A12 en combinación con bevacizumab y radioterapia alcanzan la supervivencia a los dos años en el ensayo de fase 1/2 GLORIA en cáncer cerebral	CI

Extraordinary general shareholder meeting	16/05/22	CO
Extraordinary general shareholder meeting	16/05/22	CO
Extraordinary general shareholder meeting	16/05/22	CO
Annual Report	22/04/22	CO
Annual results	22/04/22	CO
Annual results	22/04/22	CO
Annual results	22/04/22	CO
Minutes of the general assembly	15/12/21	CO
Minutes of the general assembly	15/12/21	CO
Minutes of the general assembly	15/12/21	CO
Half-year report	22/10/21	CO
1st-half-year results	22/10/21	CO
1st-half-year results	22/10/21	CO
1st-half-year results	22/10/21	CO
Changes in management and corporate officers	24/06/21	CO
Changes in management and corporate officers	24/06/21	CO
Changes in management and corporate officers	24/06/21	CO
Changes in management and corporate officers	08/02/21	CO
Changes in management and corporate officers	08/02/21	CO
Changes in management and corporate officers	08/02/21	CO
Changes in management and corporate officers	01/02/21	CO
Changes in management and corporate officers	01/02/21	CO
Changes in management and corporate officers	01/02/21	CO
Admission of new securities	26/01/21	CO
Admission of new securities	26/01/21	CO